News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,303 Results
Type
Article (88812)
Company Profile (816)
Press Release (794652)
Multimedia
Podcasts (239)
Webinars (35)
Section
Business (233604)
Career Advice (4163)
Deals (39993)
Drug Delivery (177)
Drug Development (91725)
Employer Resources (207)
FDA (18559)
Job Trends (17490)
News (398765)
Policy (40015)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3054)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (41)
Allergies (207)
Alliances (56990)
ALS (237)
Alzheimer's disease (1977)
Antibody-drug conjugate (ADC) (558)
Approvals (18911)
Artificial intelligence (881)
ASCO (345)
Autoimmune disease (363)
Automation (65)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (249)
Biotechnology (480)
Bladder cancer (212)
Brain cancer (85)
Breast cancer (840)
Cancer (6627)
Cardiovascular disease (560)
Career advice (3599)
Career pathing (52)
CAR-T (386)
CDC (76)
Celiac Disease (3)
Cell therapy (1077)
Cervical cancer (55)
Clinical research (79107)
Collaboration (2391)
Commercialization (1)
Company closure (8)
Compensation (1529)
Complete response letters (106)
COVID-19 (3043)
CRISPR (125)
C-suite (1299)
Cystic fibrosis (167)
Data (8783)
Decentralized trials (3)
Denatured (91)
Depression (197)
Dermatology (97)
Diabetes (713)
Diagnostics (7608)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (433)
Drug pricing (246)
Drug shortages (39)
Duchenne muscular dystrophy (320)
Earnings (102501)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138753)
Executive appointments (1200)
FDA (22662)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1959)
Gene editing (273)
Generative AI (90)
Gene therapy (856)
GLP-1 (1288)
Government (5562)
Grass and pollen (8)
Guidances (420)
Healthcare (21266)
Hematology (198)
HIV (97)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (356)
Immuno-oncology (116)
Indications (211)
Infectious disease (3445)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (150)
Intellectual property (324)
Interviews (822)
IPO (18006)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (123)
Layoffs (690)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (876)
Lymphoma (480)
Machine learning (68)
Management (66)
Manufacturing (1241)
Marketing (1)
MASH (227)
Medical affairs (1)
Medical device (15285)
Medtech (15452)
Mergers & acquisitions (23306)
Metabolic disorders (1840)
mRNA (271)
Multiple sclerosis (205)
NASH (24)
Neurodegenerative disease (513)
Neuropsychiatric disorders (130)
Neuroscience (3743)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5146)
Now hiring (82)
Obesity (875)
Opinion (375)
Ovarian cancer (245)
Pain (286)
Pancreatic cancer (360)
Parkinson's disease (420)
Partnered (40)
Patents (662)
Patient recruitment (770)
Peanut (71)
People (68038)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24452)
Phase 2 (34369)
Phase 3 (25834)
Pipeline (9899)
Policy (399)
Postmarket research (3560)
Preclinical (10991)
Press Release (72)
Prostate cancer (352)
Psychedelics (71)
Radiopharmaceuticals (374)
Rare diseases (1276)
Real estate (7462)
Recruiting (81)
Regulatory (30441)
Reports (77)
Research institute (2772)
Resumes & cover letters (654)
Rett syndrome (43)
RNA editing (30)
RSV (99)
Schizophrenia (197)
Series A (331)
Series B (240)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4373)
State (2)
Stomach cancer (21)
Supply chain (148)
Tariffs (104)
The Weekly (145)
Vaccines (1313)
Venture capital (135)
Weight loss (600)
Women's health (142)
Worklife (24)
Date
Today (110)
Last 7 days (537)
Last 30 days (2981)
Last 365 days (33250)
2026 (16666)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (406)
Arkansas (16)
Asia (52328)
Australia (9197)
California (14455)
Canada (4032)
China (1587)
Colorado (622)
Connecticut (644)
Delaware (448)
Europe (120688)
Florida (2153)
Georgia (469)
Hawaii (4)
Idaho (70)
Illinois (1260)
India (105)
Indiana (667)
Iowa (26)
Japan (603)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1752)
Massachusetts (10585)
Michigan (426)
Minnesota (806)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3831)
New Mexico (35)
New York (3802)
North Carolina (1945)
North Dakota (11)
Northern California (7191)
Ohio (451)
Oklahoma (27)
Oregon (55)
Pennsylvania (2842)
Puerto Rico (33)
Rhode Island (55)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5674)
Tennessee (232)
Texas (2357)
United States (51741)
Utah (430)
Vermont (1)
Virginia (372)
Washington D.C. (89)
Washington State (1190)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,303 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Essential Pharma appoints Becki Morison as Chief Executive Officer
June 18, 2026
·
3 min read
Press Releases
Amplio Spine Acquires and Commercializes KeyLift®, an FDA-Cleared Expandable Interlaminar Stabilization System Indicated for Supplemental Fusion of the Non-Cervical Spine
June 18, 2026
·
5 min read
Press Releases
Alturos Therapeutics advancement of lead candidate ALT0135, a potentially first-in-class, orally bioavailable small molecule, into IND-enabling studies
June 18, 2026
·
1 min read
Pancreatic cancer
Verastem deprioritizes pancreatic cancer work after ‘decent, but not great’ data shadowed by Revolution
Following the mid-stage readout, Verastem Oncology has decided to move away from its investigational pancreatic cancer drug combo, instead putting resources behind its KRAS inhibitor pill for solid tumors.
June 18, 2026
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Biogen makes up to $1B immuno play with RayThera takeover
RayThera will bring three preclinical assets into the Biogen fold, all with anti-inflammatory activity. The most mature of these assets is expected to enter Phase 1 development in Q3.
June 18, 2026
·
2 min read
·
Tristan Manalac
Approvals
GSK, Spero’s oral antibiotic wins first FDA nod for complicated UTI
After being rejected in June 2022, GSK paid Spero Therapeutics $66 million for an exclusive worldwide license to develop and commercialize the drug. It’s the second oral antibiotic GSK has brought to market since the beginning of last year.
June 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
IntraBio Announces Publication of Pivotal Phase III Data with Levacetylleucine for Ataxia-Telangiectasia in The Lancet Neurology
June 18, 2026
·
3 min read
Press Releases
Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada
June 18, 2026
·
6 min read
Press Releases
Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement
June 18, 2026
·
9 min read
Press Releases
BIO-Europe unveils renewed vision as the must-attend global biopharma strategy forum
June 18, 2026
·
3 min read
1 of 88,431
Next
